생명공학
Scientists identify a rocket-fuel-like reaction that propels spinning iron crystals inside malaria parasites
AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨
University of Utah researchers report that iron-rich hemozoin crystals inside the malaria parasite Plasmodium falciparum move through the parasite’s digestive compartment because reactions involving hydrogen peroxide at the crystal surface generate chemical propulsion. The work, published in Proceedings of the National Academy of Sciences, links a long-observed phenomenon to peroxide chemistry and could point to new antimalarial drug strategies and ideas for engineered micro- and nanoscale devices.
Researchers at Shandong University have modified the probiotic bacterium Escherichia coli Nissle 1917 to produce the anticancer drug Romidepsin directly in tumors. In mouse models of breast cancer, the engineered bacteria accumulated in tumors and released the drug. The findings were published on March 17 in PLOS Biology.
AI에 의해 보고됨
Scientists have genetically modified Cutibacterium acnes, a common skin bacterium, to produce more heat and detect temperature changes. This could lead to a probiotic cream that wards off frostbite and hypothermia in extreme conditions. The research was presented at a conference in the UK.
Researchers at the University of Helsinki have found that mitochondria in plant cells can draw oxygen away from chloroplasts, revealing a new interaction that affects photosynthesis and stress responses. This discovery, published in Plant Physiology, explains how plants manage internal oxygen levels. The study used genetically modified Arabidopsis thaliana plants to observe these processes.
AI에 의해 보고됨
Researchers at Lund University in Sweden have created a cell-free cartilage scaffold that guides the body to repair damaged bone. The innovation, tested successfully in animal models, avoids strong immune reactions and offers a universal alternative to patient-specific grafts. Plans are underway to test it in human clinical trials.
A team led by Leonardo Ferreira at the Medical University of South Carolina is developing a novel therapy combining lab-made insulin-producing cells with engineered immune cells to protect them. Funded by $1 million from Breakthrough T1D, the approach aims to restore beta cell function without immunosuppressive drugs. This strategy builds on prior research and targets all stages of the disease.
AI에 의해 보고됨
Sutro Biopharma, Inc. presented at the 16th Annual World ADC London Summit on February 28, 2026. The company published a slide deck in conjunction with the event.
Relmada Therapeutics holds Q4 2025 earnings conference call
2026년 03월 18일 00시 26분Biotechnology is motor for Africa's food security
2026년 03월 17일 06시 10분DNA origami “DoriVac” shows strong immune activation in early tests, offering a potential complement to mRNA vaccines
2026년 03월 12일 22시 32분Mirror-image cysteine slows cancer growth without harming healthy cells
2026년 03월 11일 14시 42분Hornwort's RbcS-STAR protein clusters Rubisco for more efficient photosynthesis
2026년 03월 06일 01시 38분Evaxion reports improved 2025 financials and transformational clinical progress
2026년 03월 06일 00시 53분Scientists identify essential protein for malaria parasite survival
2026년 03월 05일 08시 41분Venture capitalist calls for relaxing biotech listing rules in China and Hong Kong
2026년 03월 05일 02시 11분Clara Foods develops world's first animal-free pepsin
2026년 03월 03일 22시 05분ImmunityBio holds Q4 2025 earnings conference call